PHOTOCURE ASA NK-50
Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced ce… Read more
Market Cap & Net Worth: PHOTOCURE ASA NK-50 (PHS)
PHOTOCURE ASA NK-50 (F:PHS) has a market capitalization of $161.95 Million (€157.78 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #17405 globally and #1814 in its home market, demonstrating a -1.82% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PHOTOCURE ASA NK-50's stock price €5.93 by its total outstanding shares 26606672 (26.61 Million).
PHOTOCURE ASA NK-50 Market Cap History: 2018 to 2026
PHOTOCURE ASA NK-50's market capitalization history from 2018 to 2026. Data shows change from $126.45 Million to $161.95 Million (-0.05% CAGR).
PHOTOCURE ASA NK-50 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PHOTOCURE ASA NK-50's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of PHS by Market Capitalization
Companies near PHOTOCURE ASA NK-50 in the global market cap rankings as of March 18, 2026.
Key companies related to PHOTOCURE ASA NK-50 by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
PHOTOCURE ASA NK-50 Historical Marketcap From 2018 to 2026
Between 2018 and today, PHOTOCURE ASA NK-50's market cap moved from $126.45 Million to $ 161.95 Million, with a yearly change of -0.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €161.95 Million | +1.02% |
| 2025 | €160.32 Million | +10.34% |
| 2024 | €145.29 Million | -8.43% |
| 2023 | €158.68 Million | -42.19% |
| 2022 | €274.48 Million | -0.79% |
| 2021 | €276.66 Million | +3.90% |
| 2020 | €266.28 Million | +124.14% |
| 2019 | €118.80 Million | -6.05% |
| 2018 | €126.45 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of PHOTOCURE ASA NK-50 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $161.95 Million USD |
| MoneyControl | $161.95 Million USD |
| MarketWatch | $161.95 Million USD |
| marketcap.company | $161.95 Million USD |
| Reuters | $161.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.